Filing Flows › Cryoport (CYRX) › Q2 2025
Cryoport (CYRX) Q2 2025 earnings results (second quarter 2025)
10-Q filed Aug 12, 2025
Cryoport (CYRX) reported revenue of $45.5M for the second quarter 2025 (Q2 2025), +14% from a year earlier and +11% from the quarter before. Operating margin was -21.2%, net earnings $109M (239.5% of revenue).
Cryoport, Q2 2025: revenue $45.5M (+14% year over year), operating margin -21.2%, net earnings $109M, operating cash flow −$7.3M. The chart follows the revenue to costs, profit and cash.
| Q2 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $45.5M | +11% | +14% |
| Operating profit | −$9.6M | — | — |
| Net earnings | $109M | — | — |
| Operating cash flow | −$7.3M | — | — |
What changed
Revenue was $45.5M in Q2 2025, up 14% year over year and up 11% from the previous quarter. Product was the largest line at 46% of revenue. BioLogistics Solutions added $3.2M year over year (up 20%), 57% of the total change.
Gross margin was 47.0%, up 2.6 points from a year earlier. Operating costs exceeded revenue by $9.6M, an operating margin of -21.2%. Operating expenses fell 68% while revenue rose 14%. Net earnings were $108.9M. The effective tax rate was 0.3%. Non-operating items added $118.8M, 109% of pre-tax earnings, so the bottom line overstates operating performance.
Operating cash flow was −$7.3M. Non-cash charges added back $7.3M of depreciation and amortization and $2.0M of share-based compensation. Working capital and other items used $125.6M. Capital expenditures of $4.4M exceeded it, leaving free cash flow of −$11.7M.
Questions
What was Cryoport's revenue in the second quarter 2025?
Cryoport (CYRX) reported revenue of $45.5M for the second quarter 2025 (Q2 2025), +14% from a year earlier and +11% from the quarter before.
Was Cryoport profitable in the second quarter 2025?
Operating loss was $9.6M (-21.2% of revenue) and net earnings $109M.
Source: Cryoport 10-Q on SEC EDGAR.